Rocket Lab Corp Earnings Per Share Disclosure
| Years Ended December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Numerator | |||||||||||||||||
| Net loss attributable to common stockholders-basic and diluted | $ | (198,209) | $ | (190,175) | $ | (182,571) | |||||||||||
| Denominator | |||||||||||||||||
| Weighted average common shares outstanding-basic and diluted | 530,664,781 | 495,929,861 | 481,768,060 | ||||||||||||||
| Net loss per share attributable to common stockholders-basic and diluted | $ | (0.37) | $ | (0.38) | $ | (0.38) | |||||||||||
| December 31, | |||||||||||||||||
| 2025 | 2024 | 2023 | |||||||||||||||
| Stock options and restricted stock units | 17,409,519 | 28,913,838 | 26,889,125 | ||||||||||||||
| Common stock warrants | — | — | 728,835 | ||||||||||||||
| Shares underlying our convertible senior notes | 30,368,547 | 69,261,530 | — | ||||||||||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.